
PRTT does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PRTT and 80,000+ other tickers.
See exactly how PRTT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PRTT and 80,000+ other tickers.
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.

Company will operate under the Arvia brand, with the Vacterra brand retained exclusively for its hydrovac truck operations CHEYENNE, WY / ACCESS Newswire / August 18, 2026 / Protect Pharmaceutical Corp. (OTCID:PRTT) (the "Company" or "PRTT") today announced that its wholly owned Canadian subsidiary has completed the acquisition of Vacterra Hydrovac Inc. ("Vacterra") and Clearwater Environmental Ltd. ("Clearwater") from Horizon Enterprises Ltd.

ANKARA, Turkey, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) (“Company”) and Atlantic Logistics announce there will be no merger with KARINCA Logistics.

ANKARA, Turkey, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ("Company") announces the appointment of a new CEO, restructuring of the Board of Directors, and looks to finalize the merger agreement with Karinca Logistics - www.karincalogistics.com . The Company appointed Ozgur Ozcan as CEO and Director and George Athanasiadis as Director.

ANKARA, Turkey, July 01, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: "July 1, 2024 Dear Shareholders: The Company's PCAOB audit for the fiscal year of 2023 is near completion. We have a few items remaining that are required to be completed by the local jurisdiction of the company in Turkey.

ISTANBUL, Turkey, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) President, Ali Yildiz, publishes his February 2024 corporate update letter to Company Shareholders as follows: "February 5, 2024 Dear Shareholders: Management announces that it has finalized its 2021 and 2022 financials, and the audit can be announced as completed. The Company is drafting a Form 10 registration statement that will be filed with the SEC to resume reporting to the SEC.